| Results summary | View all lists in L2L MDB | View all genes in C01C.profile.u50 |
|
Up-regulated in human hepatoma cells (HepG2) following 48 hrs treatment with 2.5 microM 5-aza-2-deoxycytidine (5azaC). enrichment: 1.99-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 205203_AT | PLD1 | E | S | phospholipase D1, phosphatidylcholine-specific | |||||||||
| 218729_AT | LXN | latexin | |||||||||||
| 203649_S_AT | PLA2G2A | E | phospholipase A2, group IIA (platelets, synovial fluid) | ||||||||||
| 204907_S_AT | BCL3 | G | T | D | X | P | R | S | B-cell CLL/lymphoma 3 | ||||
| 206242_AT | TM4SF5 | P | transmembrane 4 L six family member 5 | ||||||||||
| 210355_AT | PTHLH | G | D | C | S | parathyroid hormone-like hormone | |||||||
| 205386_S_AT | MDM2 | G | P | R | Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) | ||||||||
| 204713_S_AT | F5 | X | C | coagulation factor V (proaccelerin, labile factor) | |||||||||